Project Grant DP2DA062283
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$2.5M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $419,876 to conduct preclinical trials targeting the neuropeptide S (NPS) receptor to mitigate opioid taking and seeking behaviors in animal models. The goals of the project are to demonstrate proof-of-concept that NPS receptor-targeted molecules can reduce oxycodone self-administration and motivation in rats, which could inform the...
This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...
This federal Project Grant award of $2,332,500.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a novel model of a prison learning health system to address disparities in HIV treatment, HIV prevention, and substance use disorder (SUD) treatment among incarcerated individuals. The key objectives of this project, which will be embedded in Washington's state prisons, are to: 1) build the foundation for a...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is providing $1,994,766 to the Cambridge Public Health Commission (doing business as Cambridge Health Alliance) to assess the causal impact and equity effects of the New York State Medicaid Value-Based Payment (VBP) policy on opioid use disorder (OUD)-related outcomes. The key products and services being delivered include: Evaluating the overall...
This $1,717,200 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Pittsburgh. The grant aims to identify and validate G protein-coupled receptors (GPCRs) expressed by prefrontal cortex somatostatin-expressing inhibitory neurons, with the goal of developing breakthrough treatments for opioid use disorder (OUD). The research will use an unbiased transcriptomics approach to identify GPCR...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a novel nurse-led Community-Based Opioid Treatment (CBOT) model to deliver opioid use disorder treatment and HIV prevention/care services in community settings. The $2,332,500 award to the University of Washington will be used to (1) interview patients, providers, and stakeholders to inform CBOT implementation, (2)...
The National Institute on Drug Abuse (NIDA) awarded a $193,336 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Trustees of Dartmouth College to evaluate a pharmacist-integrated model of opioid use disorder (OUD) treatment in primary care settings. The goal is to investigate if this model can increase the co-prescribing of naloxone, the opioid overdose antidote, to patients receiving medication treatment for OUD. The research project aims to: 1) describe federal,...
This $598,312 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate and assess the practicality of a closed-loop medication management system for opioid pain management in emergency department patients with extremity fractures. The key product being developed and evaluated is the ADDINEX system, which packages opioid medications in mechanical dispensers that restrict access to individual...
The National Institute on Drug Abuse (NIDA) awarded a $1,039,420 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Medical University of South Carolina (MUSC). The grant, effective June 1, 2025 through February 28, 2030, will support research to characterize the transcriptomic profile and function of single neurons and unique neuronal ensembles in brain circuits that govern the facilitation and disinhibition of alcohol and opioid seeking behaviors. The project...
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The award supports a participatory approach to create English and Spanish-language multimedia materials, including short videos and graphic novels, to address...